Combination treatment with antigen-specific dual-sized microparticle system plus anti-CD3 immunotherapy fails to synergize to improve late-stage type 1 diabetes prevention in non-obese diabetic mice

Type 1 diabetes (T1D) pathophysiology, while incompletely understood, has in part been attributed to aberrant presentation of self-antigen plus proinflammatory costimulation by professional antigen...